The USDA APHIS has granted $2 million to a Purdue University-led research team, including Entomol and 1,4Group, to test a hydrogenated catmint oil fogging technology against highly pathogenic avian influenza (HPAI) in poultry environments.
According to an official disclosure, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has awarded $2 million to a research consortium headed by Purdue University to evaluate a novel antiviral fogging system targeting highly pathogenic avian influenza (HPAI).
The project involves collaborators Entomol and 1,4Group, and is led by Dr. Ekramy Sayedahmed, Assistant Professor of Poultry Medicine at Purdue’s College of Veterinary Medicine. The technology employs hydrogenated catmint oil (HCO), a natural compound supplied by Entomol Products, LLC, to inhibit viral propagation within poultry housing. Research will progress from laboratory antiviral testing to safety assessments in chickens and field efficacy trials under real-world conditions.
Purdue University is a public land-grant research institution in Indiana, with a specialized poultry medicine program. Entomol is a developer of plant-derived bioactive compounds. This development matters because HPAI remains a persistent threat to global poultry supplies, causing significant economic losses and trade disruptions.
For the poultry industry, biosecurity equipment manufacturers, and large-scale integrators, an effective fogging solution could add a critical layer of outbreak prevention. Investors in animal health and ag-tech should monitor trial outcomes, as regulatory approval could open a new category of natural antiviral interventions for livestock facilities.
About GlobeNewsInfo
GlobeNewsInfo.com is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.